The National Institute for Health and Care Excellence (NICE) has approved Tirzepatide andSemaglutide, two medications, for the management of overweight and obesity.The NHS is now rolling out these medications for people who meet the eligibility criteria,starting with people who are at highest risk of ill health, or who are experiencing the mostsevere ill health due
Specialist Weight Loss Injections (Tirzepatide/Mounjaro®) in Cambridgeshire and Peterborough
